MetaCap

Immunic (IMUX) News

NASDAQ: IMUXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.99-0.40 (-5.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IMUX news summary

We found 7 recent headlines mentioning Immunic (IMUX): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, PR Newswire. IMUX is making an outsized move today, down 5.41% at $6.99, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Immunic Q3 Loss Widens On Higher Expenses; Phase 3 MS Trial Data Expected In December 2026", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Immunic headlines

Stocks mentioned alongside IMUX

Compare IMUX